NCT02987179

Brief Summary

The clinical diagnosis of sleep apnea is difficult among ESRD patients since the characteristic clinical features of sleep apnea may be absent and since sleep-related symptoms, such as fatigue and sleepiness, may be attributed to kidney failure. However, the evaluation of patients with possible sleep apnea is the same among ESRD patients as in the general population.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Dec 2016

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2016

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

December 6, 2016

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 8, 2016

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2017

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2017

Completed
Last Updated

December 8, 2016

Status Verified

December 1, 2016

Enrollment Period

3 months

First QC Date

December 6, 2016

Last Update Submit

December 6, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • Identifying Intradialytis desaturation episodes

    • To determine the sensitivity and specificity of the CLM for identifying intradialytic desaturation episodes, using the WatchPAT device as the reference method.

    1 week

Study Arms (1)

ESRD Patients

The following inclusion criteria must be met for each subject. * Age ≥18 years and able to give written informed consent to the study * On chronic hemodialysis for ≥ 90 days at time of enrollment * Ability to read * Consent to have video recording taken during study visit

Other: Observational

Interventions

Collect anthropomorphic, WatchPAT, Crit-line Monitor measurements as well as sleep questionnaires and video records

ESRD Patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Chronic hemodialysis patients

You may qualify if:

  • Age ≥18 years and able to give written informed consent to the study
  • On chronic hemodialysis for ≥ 90 days at time of enrollment
  • Ability to read
  • Consent to have video recording taken during study visit

You may not qualify if:

  • Subjects with cognitive impairment to consent
  • Sickle cell anemia
  • Prescription of nasal oxygen
  • Simultaneous participation in another clinical trial that may affect breathing frequency/patterns, blood oxygenation, sleep/wake cycle or other parameters related to the outcomes of interest to this study
  • Use of a breathing device, e.g. CPAP
  • Central venous catheter used as vascular access for hemodialysis
  • Artificial fingernails (may disturb the measurement of the WatchPAT)
  • Use of one of the following medications: alpha blockers, short acting nitrates (less than 3 hours before the study).
  • Permanent pacemaker
  • Sustained non-sinus cardiac arrhythmias.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Renal Research Institute

New York, New York, 10065, United States

Location

MeSH Terms

Conditions

Kidney Failure, ChronicSleep Apnea SyndromesHypoxia

Interventions

Watchful Waiting

Condition Hierarchy (Ancestors)

Renal Insufficiency, ChronicRenal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesSigns and Symptoms, RespiratorySigns and Symptoms

Intervention Hierarchy (Ancestors)

Outcome Assessment, Health CareOutcome and Process Assessment, Health CareQuality of Health CareHealth Services Administration

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 6, 2016

First Posted

December 8, 2016

Study Start

December 1, 2016

Primary Completion

March 1, 2017

Study Completion

December 1, 2017

Last Updated

December 8, 2016

Record last verified: 2016-12

Locations